Celemics Inc. (331920) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Celemics Inc. (331920:KRX), powered by AI.

Current Price
₩13,000
P/E Ratio
8.7
Market Cap
106.1B
Sector
Healthcare
What is the Celemics Inc. stock price forecast?

Celemics Inc. is currently trading at ₩13,000. View real-time AI analysis on Alpha Lenz.

What is Celemics Inc. insider trading activity?

View the latest insider trading data for Celemics Inc. on Alpha Lenz.

What is Celemics Inc.'s P/E ratio?

Celemics Inc.'s P/E ratio is 8.7.

Celemics Inc.

KRX · 331920
₩13,000
Ask about Celemics Inc.'s future dividend policy...
Alpha Chat Insight

Celemics Inc. trades at a P/E of 8.7 (undervalued) with strong ROE of 57.0%.

Ask for details

Company Overview

Celemics Inc. is a biotechnology company that specializes in providing next-generation sequencing (NGS) solutions for various research and clinical applications. The company is renowned for its innovative Complete Reagent Solution, which enhances the efficiency and accuracy of genomic sequencing processes. Offering targeted sequencing panels, whole exome sequencing, and whole-genome sequencing, Celemics serves a plethora of industries including healthcare, pharmaceuticals, and academic research institutions. By enabling precise and comprehensive genomic analysis, Celemics plays a pivotal role in advancing personalized medicine, genetic research, and the development of new diagnostics and therapies. Founded with a commitment to quality and innovation, Celemics is instrumental in pushing the boundaries of genetic analysis, ensuring that researchers and clinicians can achieve profound insights into complex biological questions. Through its products and services, the company significantly impacts how genetic data is utilized for medical and scientific advancements.

CEO김효기, 이용훈
SectorHealthcare
IndustryMedical Devices
Employees41

Company Statistics

FY 2024

Profile

₩106,133,924,000Market Cap
₩6,718,995,000Revenue
8.16MShares Out
41Employees

Margins

54.72%Gross
-8.12%EBITDA
-28.32%Operating
182.56%Pre-Tax
182.56%Net

Valuation

8.65P/E
3.90P/B
15.80EV/Sales
-188.23EV/EBITDA
-213.58P/FCF

Growth (CAGR)

-5.98%Rev 3Yr
5.50%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

51.61%ROA
56.97%ROE
51.73%ROIC

Financial Health

₩3,960,972,950Cash & Cash Equivalents
₩-1,731,186,060Net Debt
8.20%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Celemics Inc. (ticker: 331920) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 41 employees. Market cap is $106.1B.

The current price is ₩13,000 with a P/E ratio of 8.65x and P/B of 3.9x.

ROE is 56.97% and operating margin is -28.32%. Annual revenue is $6.7B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Celemics Inc. (Healthcare) Stock Forecast & Analysis ₩13,000 | Alpha Lenz